Our ophthalmology program performs basic science and clinical research. We study the treatment of age-related macular degeneration and diabetic macular edema and are involved in numerous clinical trials. We have been involved in more than 45 clinical trials for patients with various ocular diseases, including age-related macular degeneration, central retinal vein occlusion, diabetic retinopathy, glaucoma and dry eye disease.
Irwin Retina Center Research
The Irwin Retina Center is located within UChicago Medicine Ingalls Memorial, where eye specialists are engaged in a number of research grants and clinical trials sponsored by the National Institutes of Health and the National Eye Institute. There are numerous FDA studies on new drugs and treatments for retinal diseases patients can participate in.
Equipped with the most advanced diagnostic and treatment procedures available, the center offers:
- Digital eye imaging
- Fluorescein and indocyanine green angiography to study normal and abnormal blood vessels in the back of the eye
- B-scan ultrasonography, which helps identify abnormalities not visible with other instrumentation
- Visual field testing to measure central and peripheral visual field defects
- Retinal laser treatment
- Intravitreal injections to treat retinal diseases. Injections include the very latest therapies approved by the FDA
Toxoplasmosis Center Research
Directed by an internationally recognized and award-winning toxoplasmosis specialist, our toxoplasmosis center is dedicated to finding ways to prevent and treat this disease. Over the years, we have led national, multicenter studies to understand how T. gondii causes disease. We are leading a multi-center team that is studying new approaches to treating acute and chronic toxoplasmosis infection. Additional research into vaccines, new medicines, genetics of susceptibility and resistance and other basic aspects of this infection and the parasite that causes it is under way.